9 results
Algorithmic Approach to Anemia - Differential Diagnosis Framework by MCV

Microcytic (MCV < 80) "TAILS":
 • Thalassemia
Algorithmic Approach ... Diagnosis Framework ... Hemolytic: ... #MCV #Algorithm ... #hematology
Algorithm for the evaluation of macrocytic anemia. (RBC = red blood cell; MMA = methylmalonic acid.)
Physicians
Algorithm for the ... evaluation of macrocytic ... serum level for all ... Hemorrhage or hemolysis ... #Diagnosis #Macrocytosis
General Approach to Anemia - Differential Diagnosis Framework
1) Check reticulocyte count to determine if hypo/hyper-proliferative
2) Exclude
General Approach to Anemia ... - Differential Diagnosis ... hyper-proliferative 2) Exclude hemolysis ... guide further evaluation ... #hematology #algorithm
Clinical Algorithm for Emergency Department Evaluation and Management of UTI in Febrile Infants and Young Children

Urinary
Emergency Department Evaluation ... and Management ... applicable for all ... #Diagnosis #Management ... Febrile #Infant #Peds
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
Algorithm regarding ... the diagnosis and ... Step 3: All patients ... #diagnosis #management ... #hepatology #gastroenterology
Paraproteinemias

Entities That Can Feature A Monoclonal Protein/M Component:
• MM
• WM
• MGUS
• MGCS
• MGRS
• Splenic Marginal Zone
Evans • ITP • Cl-NH ... • Coombs (-) hemolytic ... anemia due to cold ... Paraproteinemias #Hematology ... #Differential #Diagnosis
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
accounts for 10% of all ... Weight loss • Anemia ... nodosum • Immune hemolytic ... anemia • Pain ... #oncology #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk Evaluation ... algorithm to determine ... medical and surgical management ... perioperative #Risk #Evaluation ... stratification #diagnosis
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... median age at diagnosis ... disease tolerate anemia ... #algorithm #hematology